T 1107/22 of 07.03.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T110722.20240307
- Date of decision
- 7 March 2024
- Case number
- T 1107/22
- Petition for review of
- -
- Application number
- 14720369.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CRYSTALLINE DIHYDROCHLORIDE HYDRATE SALT OF OMECAMTIV MECARBIL AND PROCESS FOR ITS PREPARATION
- Applicant name
- Amgen Inc.
Cytokinetics, Inc. - Opponent name
- KELTIE LLP
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56 1973
- Keywords
- Inventive step
- Catchword
- -
- Cited cases
- T 0500/16
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of the claims of the main request filed as auxiliary request 10 with the patent proprietors' reply to the opponent's appeal and a description and drawings possibly adapted thereto.